Henrik Sundin

Henrik Sundin appears in our data through filings on Hamlet BioPharma AB shares, published by Finansinspektionen. In total, 8 filings cover trades dated from 22 May 2026 to 25 May 2026.

On the market, this insider has only sold: 8 sales, €77k in total.

The record was last updated on 25 May 2026 with an open-market sale (€6,894) in Hamlet BioPharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.